The non-classical human leukocyte antigen G (HLA-G) is expressed at a high frequency in renal cell carcinoma (RCC) and is associated with a higher tumor grade and a poor clinical outcome. Here, HLA-G is linked to hereditary clear cell renal cell carcinoma.